West Pharmaceutical Services Other intangible assets—net decreased by 9.1% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.0%, from $10.00M to $7.00M. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows a downward trend with a -24.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.80M | $26.10M | $23.00M | $21.80M | $20.00M | $18.10M | $18.40M | $17.80M | $16.80M | $15.70M | $15.10M | $13.90M | $12.90M | $12.30M | $10.80M | $10.00M | $9.70M | $8.90M | $7.70M | $7.00M |
| QoQ Change | — | -6.1% | -11.9% | -5.2% | -8.3% | -9.5% | +1.7% | -3.3% | -5.6% | -6.5% | -3.8% | -7.9% | -7.2% | -4.7% | -12.2% | -7.4% | -3.0% | -8.2% | -13.5% | -9.1% |
| YoY Change | — | — | — | — | -28.1% | -30.7% | -20.0% | -18.3% | -16.0% | -13.3% | -17.9% | -21.9% | -23.2% | -21.7% | -28.5% | -28.1% | -24.8% | -27.6% | -28.7% | -30.0% |